Filing Flows › BioMarin Pharmaceutical (BMRN) › Operating margin
BioMarin Pharmaceutical (BMRN) operating margin by quarter
BioMarin Pharmaceutical's operating margin was 11.2% in Q2 2026 (second quarter 2026), -5.7 pts from Q1 2026. Over the last 4 quarters it ranged from 11.2% (Q2 2026) to 33.5% (Q2 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 11.2% | -5.7 pts | -22.3 pts |
| Q1 2026 | 16.9% | -16.6 pts | -13.1 pts |
| Q2 2025 | 33.5% | +3.5 pts | — |
| Q1 2025 | 30.0% | — | — |
Q2 2026 at a glance
BioMarin Pharmaceutical, Q2 2026: revenue $990M (+20% year over year), operating margin 11.2%, net earnings $44.8M, operating cash flow $168M. The chart follows the revenue to costs, profit and cash.
Questions
What is BioMarin Pharmaceutical's operating margin?
BioMarin Pharmaceutical's operating margin was 11.2% in Q2 2026 (second quarter 2026), -5.7 pts from Q1 2026.
How has BioMarin Pharmaceutical's operating margin changed?
Over the last 4 quarters it ranged from 11.2% (Q2 2026) to 33.5% (Q2 2025).
Q2 2026 results → · How BioMarin Pharmaceutical makes money →